Search

everythinglearnresearchcommunity

for

Search:↓

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Dutasteride may help reduce brain inflammation and improve cognition.

Dutasteride injections can help treat hair loss in men and women.

Simvastatin may help manage symptoms in women with non-classic congenital adrenal hyperplasia by lowering cholesterol and certain hormone levels.

Metformin and liraglutide improved symptoms of HAIR-AN syndrome in a child.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Dutasteride may help reduce brain plaque linked to Alzheimer's by affecting cell energy structures and waste removal.

Avicennia marina extract and avicequinone C can potentially promote hair growth and treat hair loss by interfering with hair loss mechanisms and boosting growth factors.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

Advocacy groups should avoid marketing partnerships that may imply drug endorsements.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Finasteride may worsen blood sugar control in diabetic patients.

Dutasteride may reduce insulin sensitivity and increase body fat.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

ATP helps prevent skin damage from vandetanib by reducing stress.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The nanoemulsion of Avicennia marina extract effectively fights dandruff.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Upadacitinib effectively treats severe alopecia areata and is safe.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.